Cloudflare Inc vs Nuvation Bio Inc. Class A Common Stock — how do they compare? Cloudflare Inc trades at $344 (market cap $122.12B), while Nuvation Bio Inc. Class A Common Stock trades at $4.95 (market cap $1.71B). The key difference: Cloudflare Inc is far larger — about 71.4× Nuvation Bio Inc. Class A Common Stock's market cap, and Cloudflare Inc is trading nearer its 52-week high, Nuvation Bio Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Cloudflare Inc for 61 Days and Nuvation Bio Inc. Class A Common Stock for 0 Days on average.
| NET | NUVB | |
|---|---|---|
Market Cap | $122.12B | $1.71B |
Volume | 2,321,930 | 5,448,712 |
Sector | Technology | Health |
52-Week High | $359.60 | $9.54 |
52-Week Low | $160.16 | $3.41 |
Typical Hold Time | 61 Days | 0 Days |
Enterprise Value | $121.49B | $1.30B |
Signals from Pluang's Aura AI — not financial advice
Cloudflare (NET) trades at $341.70, down 3.75% on the day, with a bullish technical signal from moving averages and neutral oscillators. Revenue growth is strong, reaching $2.17 billion in 2025, but the company remains unprofitable with a net income margin of -8.21%. Recent news highlights product launches like Cloudflare Basin and partnerships, such as with Deutsche Telekom, driving positive sentiment. The stock is near its 52-week high, reflecting investor optimism around its AI and security offerings.
Outlook is mixed: robust revenue growth and analyst bullishness (70.7% buy ratings) support upside, but high valuations (P/S of 48.03) and persistent losses pose risks. Investors should weigh growth potential against profitability challenges and market volatility.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Cloudflare is a software company based in San Francisco, California, that offers security and web performance offerings by utilizing a distributed, serverless content delivery network, or CDN. The firm's edge computing platform, Workers, leverages this network by providing clients the ability to deploy, and execute code without maintaining servers.
Read more on NET →Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →